Skip to main content
NCBI home page
Canadian Family Physician logoLink to Canadian Family Physician
. 1997 Jul;43:1249–1254.

Strategies for diagnosing and managing medication-induced headache.

J G Edmeads 1, M J Gawel 1, J Vickers 1
PMCID: PMC2255116  PMID: 9241463

Abstract

PROBLEM ADDRESSED: Headache is a common clinical disorder. Nearly 50% of patients with headaches use prescription medications, and 90% regularly use nonprescription drugs. Medication-induced headaches (MIH) are chronic daily headaches caused by overuse of medicine. OBJECTIVES: To summarize the diagnostic criteria for MIH, to determine the investigations necessary to confirm the diagnosis and exclude other possible diagnoses, and to establish recommendations for managing MIH. MAIN FINDINGS: Diagnosis of MIH is based on patient's history and the clinical characteristics of the headache. Treatment includes patient education and support, withdrawal of offending medications, relief of withdrawal symptoms, and specific treatment of residual headache. When migraine and other causes of headache are adequately addressed, patients will not seek additional pain relief. CONCLUSION: Medication-induced headache is preventable. The key to prevention is appropriate drug therapy to relieve the primary headache. All patients with MIH can be treated and most cured.

Full text

PDF
1249

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akpunonu B. E., Mutgi A. B., Federman D. J., Volinsky F. G., Brickman K., Davis R. L., Gilbert C., Asgharnejad M. Subcutaneous sumatriptan for treatment of acute migraine in patients admitted to the emergency department: a multicenter study. Ann Emerg Med. 1995 Apr;25(4):464–469. doi: 10.1016/s0196-0644(95)70259-8. [DOI] [PubMed] [Google Scholar]
  2. Amery W. K., Caers L. I., Aerts T. J. Flunarizine, a calcium entry blocker in migraine prophylaxis. Headache. 1985 Jul;25(5):249–254. doi: 10.1111/j.1526-4610.1985.hed2505249.x. [DOI] [PubMed] [Google Scholar]
  3. Bánk J. A comparative study of amitriptyline and fluvoxamine in migraine prophylaxis. Headache. 1994 Sep;34(8):476–478. doi: 10.1111/j.1526-4610.1994.hed3408476.x. [DOI] [PubMed] [Google Scholar]
  4. Cady R. K., Wendt J. K., Kirchner J. R., Sargent J. D., Rothrock J. F., Skaggs H., Jr Treatment of acute migraine with subcutaneous sumatriptan. JAMA. 1991 Jun 5;265(21):2831–2835. [PubMed] [Google Scholar]
  5. Callaham M., Raskin N. A controlled study of dihydroergotamine in the treatment of acute migraine headache. Headache. 1986 Apr;26(4):168–171. doi: 10.1111/j.1526-4610.1986.hed2604168.x. [DOI] [PubMed] [Google Scholar]
  6. Capildeo R., Rose F. C. Single-dose pizotifen, 1.5 mg nocte: a new approach in the prophylaxis of migraine. Headache. 1982 Nov;22(6):272–275. doi: 10.1111/j.1526-4610.1982.hed2206272.x. [DOI] [PubMed] [Google Scholar]
  7. Couch J. R., Hassanein R. S. Amitriptyline in migraine prophylaxis. Arch Neurol. 1979 Nov;36(11):695–699. doi: 10.1001/archneur.1979.00500470065013. [DOI] [PubMed] [Google Scholar]
  8. Diamond S., Kudrow L., Stevens J., Shapiro D. B. Long-term study of propranolol in the treatment of migraine. Headache. 1982 Nov;22(6):268–271. doi: 10.1111/j.1526-4610.1982.hed2206268.x. [DOI] [PubMed] [Google Scholar]
  9. Edmeads J., Findlay H., Tugwell P., Pryse-Phillips W., Nelson R. F., Murray T. J. Impact of migraine and tension-type headache on life-style, consulting behaviour, and medication use: a Canadian population survey. Can J Neurol Sci. 1993 May;20(2):131–137. doi: 10.1017/s0317167100047697. [DOI] [PubMed] [Google Scholar]
  10. Goadsby P. J., Zagami A. S., Donnan G. A., Symington G., Anthony M., Bladin P. F., Lance J. W. Oral sumatriptan in acute migraine. Lancet. 1991 Sep 28;338(8770):782–783. doi: 10.1016/0140-6736(91)90666-d. [DOI] [PubMed] [Google Scholar]
  11. Gold M. S., Redmond D. E., Jr, Kleber H. D. Clonidine blocks acute opiate-withdrawal symptoms. Lancet. 1978 Sep 16;2(8090):599–602. doi: 10.1016/s0140-6736(78)92823-4. [DOI] [PubMed] [Google Scholar]
  12. Gross M. L., Kay J., Turner A. M., Hallett K., Cleal A. L., Hassani H. Sumatriptan in acute migraine using a novel cartridge system self-injector. United Kingdom Study Group. Headache. 1994 Nov-Dec;34(10):559–563. doi: 10.1111/j.1526-4610.1994.hed3410559_a.x. [DOI] [PubMed] [Google Scholar]
  13. Havanka-Kanniainen H. Treatment of acute migraine attack: ibuprofen and placebo compared. Headache. 1989 Sep;29(8):507–509. doi: 10.1111/j.1526-4610.1989.hed2908507.x. [DOI] [PubMed] [Google Scholar]
  14. Jensen R., Brinck T., Olesen J. Sodium valproate has a prophylactic effect in migraine without aura: a triple-blind, placebo-controlled crossover study. Neurology. 1994 Apr;44(4):647–651. doi: 10.1212/wnl.44.4.647. [DOI] [PubMed] [Google Scholar]
  15. Kloster R., Nestvold K., Vilming S. T. A double-blind study of ibuprofen versus placebo in the treatment of acute migraine attacks. Cephalalgia. 1992 Jun;12(3):169–128. doi: 10.1046/j.1468-2982.1992.1203169.x. [DOI] [PubMed] [Google Scholar]
  16. Kudrow L. Paradoxical effects of frequent analgesic use. Adv Neurol. 1982;33:335–341. [PubMed] [Google Scholar]
  17. Lamsudin R., Sadjimin T. Comparison of the efficacy between flunarizine and nifedipine in the prophylaxis of migraine. Headache. 1993 Jun;33(6):335–338. doi: 10.1111/j.1526-4610.1993.hed3306335.x. [DOI] [PubMed] [Google Scholar]
  18. Lawrence E. R., Hossain M., Littlestone W. Sanomigran for migraine prophylaxis, controlled multicenter trial in general practice. Headache. 1977 Jul;17(3):109–112. doi: 10.1111/j.1526-4610.1977.hed1703109.x. [DOI] [PubMed] [Google Scholar]
  19. Markley H. G., Cheronis J. C., Piepho R. W. Verapamil in prophylactic therapy of migraine. Neurology. 1984 Jul;34(7):973–976. doi: 10.1212/wnl.34.7.973. [DOI] [PubMed] [Google Scholar]
  20. Mathew N. T., Kurman R., Perez F. Drug induced refractory headache--clinical features and management. Headache. 1990 Oct;30(10):634–638. doi: 10.1111/j.1526-4610.1990.hed3010634.x. [DOI] [PubMed] [Google Scholar]
  21. Mathew N. T., Saper J. R., Silberstein S. D., Rankin L., Markley H. G., Solomon S., Rapoport A. M., Silber C. J., Deaton R. L. Migraine prophylaxis with divalproex. Arch Neurol. 1995 Mar;52(3):281–286. doi: 10.1001/archneur.1995.00540270077022. [DOI] [PubMed] [Google Scholar]
  22. Mathew N. T. Transformed migraine. Cephalalgia. 1993 Apr;13 (Suppl 12):78–83. doi: 10.1177/0333102493013S1217. [DOI] [PubMed] [Google Scholar]
  23. Meyer J. S., Hardenberg J. Clinical effectiveness of calcium entry blockers in prophylactic treatment of migraine and cluster headaches. Headache. 1983 Nov;23(6):266–277. doi: 10.1111/j.1526-4610.1983.hed2306266.x. [DOI] [PubMed] [Google Scholar]
  24. Nappi G., Sicuteri F., Byrne M., Roncolato M., Zerbini O. Oral sumatriptan compared with placebo in the acute treatment of migraine. J Neurol. 1994 Jan;241(3):138–144. doi: 10.1007/BF00868340. [DOI] [PubMed] [Google Scholar]
  25. Pavese N., Baracchini G., Bonuccelli U. Valproate-withdrawal induced migraine. Headache. 1994 Jul-Aug;34(7):445–445. doi: 10.1111/j.1526-4610.1994.hed3407445_1.x. [DOI] [PubMed] [Google Scholar]
  26. Ryan R. E., Sr, Ryan R. E., Jr, Sudilovsky A. Nadolol: its use in the prophylactic treatment of migraine. Headache. 1983 Jan;23(1):26–31. doi: 10.1111/j.1526-4610.1983.hed2301026.x. [DOI] [PubMed] [Google Scholar]
  27. Saper J. R. Ergotamine dependency--a review. Headache. 1987 Sep;27(8):435–438. doi: 10.1111/j.1526-4610.1987.hed2708435.x. [DOI] [PubMed] [Google Scholar]
  28. Silberstein S. D., Silberstein J. R. Chronic daily headache: long-term prognosis following inpatient treatment with repetitive IV DHE. Headache. 1992 Oct;32(9):439–445. doi: 10.1111/j.1526-4610.1992.hed3209439.x. [DOI] [PubMed] [Google Scholar]
  29. Solomon G. D., Steel J. G., Spaccavento L. J. Verapamil prophylaxis of migraine. A double-blind, placebo-controlled study. JAMA. 1983 Nov 11;250(18):2500–2502. [PubMed] [Google Scholar]
  30. Solomon G. D. Therapeutic advances in migraine. J Clin Pharmacol. 1993 Mar;33(3):200–209. doi: 10.1002/j.1552-4604.1993.tb03944.x. [DOI] [PubMed] [Google Scholar]
  31. Stensrud P., Sjaastad O. Comparative trial of Tenormin (atenolol) and Inderal (propranolol) in migraine. Headache. 1980 Jul;20(4):204–207. doi: 10.1111/j.1526-4610.1980.h2004006.x. [DOI] [PubMed] [Google Scholar]
  32. Treves T. A., Streiffler M., Korczyn A. D. Naproxen sodium versus ergotamine tartrate in the treatment of acute migraine attacks. Headache. 1992 Jun;32(6):280–282. doi: 10.1111/j.1526-4610.1992.hed3206280.x. [DOI] [PubMed] [Google Scholar]
  33. Washton A. M., Resnick R. B. Clonidine for opiate detoxification: outpatient clinical trials. Am J Psychiatry. 1980 Sep;137(9):1121–1122. doi: 10.1176/ajp.137.9.1121. [DOI] [PubMed] [Google Scholar]
  34. Weber R. B., Reinmuth O. M. The treatment of migraine with propranolol. Neurology. 1972 Apr;22(4):366–369. doi: 10.1212/wnl.22.4.366. [DOI] [PubMed] [Google Scholar]
  35. Weisz M. A., el-Raheb M., Blumenthal H. J. Home administration of intramuscular DHE for the treatment of acute migraine headache. Headache. 1994 Jun;34(6):371–373. doi: 10.1111/j.1526-4610.1994.hed3406371.x. [DOI] [PubMed] [Google Scholar]
  36. Winner P., Dalessio D., Mathew N., Sadowsky C., Turkewitz L. J., Sheftell F., Silberstein S. D., Solomon S. Office-based treatment of acute migraine with dihydroergotamine mesylate. Headache. 1993 Oct;33(9):471–475. doi: 10.1111/j.1526-4610.1993.hed3309471.x. [DOI] [PubMed] [Google Scholar]
  37. Wöber C., Wöber-Bingöl C., Koch G., Wessely P. Long-term results of migraine prophylaxis with flunarizine and beta-blockers. Cephalalgia. 1991 Dec;11(6):251–256. doi: 10.1046/j.1468-2982.1991.1106251.x. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Family Physician are provided here courtesy of College of Family Physicians of Canada

RESOURCES